These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31486901)

  • 21. Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor.
    Cheung CC; Cadnapaphornchai MA; Ranadive SA; Gitelman SE; Rosenthal SM
    Int J Pediatr Endocrinol; 2012 Feb; 2012(1):3. PubMed ID: 22325688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. V2 vasopressin receptor mutations.
    Makita N; Manaka K; Sato J; Iiri T
    Vitam Horm; 2020; 113():79-99. PubMed ID: 32138955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.
    Erdélyi LS; Hunyady L; Balla A
    Front Endocrinol (Lausanne); 2023; 14():1173601. PubMed ID: 37293495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment.
    Tamma G; Di Mise A; Ranieri M; Geller A; Tamma R; Zallone A; Valenti G
    J Cell Mol Med; 2017 Sep; 21(9):1767-1780. PubMed ID: 28326667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrogenic syndrome of inappropriate antidiuresis - An ethnically, genetically and phenotypically diverse disorder: First report in a Chinese adult and review of published cases.
    Tong HF; Leung MTS; Chan CHT; Cheung HN; Mak WLT; Chen PLS
    Clin Chim Acta; 2021 Aug; 519():214-219. PubMed ID: 33984325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells.
    Di Mise A; Venneri M; Ranieri M; Centrone M; Pellegrini L; Tamma G; Valenti G
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vasopressin-aquaporin-2 pathway syndromes.
    Valenti G; Tamma G
    Handb Clin Neurol; 2021; 181():249-259. PubMed ID: 34238461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephrogenic syndrome of inappropriate antidiuresis: Early diagnosis avoids severe hyponatremia complications].
    Cailleaux A; Mahieu F; Heinrichs C; Adams B; Ismaili K; Brachet C
    Arch Pediatr; 2017 Jul; 24(7):630-633. PubMed ID: 28583780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic drugs upregulate aquaporin-2 via vasopressin-2 receptor/cAMP/protein kinase A signaling in inner medullary collecting duct cells.
    Kim S; Jo CH; Kim GH
    Am J Physiol Renal Physiol; 2021 May; 320(5):F963-F971. PubMed ID: 33843270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
    Juul KV; Bichet DG; Nielsen S; Nørgaard JP
    Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic Diabetes Insipidus.
    Balla A; Hunyady L
    Exp Suppl; 2019; 111():317-339. PubMed ID: 31588538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia.
    Kim S; Jo CH; Kim GH
    Front Physiol; 2021; 12():797039. PubMed ID: 34955900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of Drug-Induced Hyponatremia.
    Kim GH
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment.
    Bouley R; Hawthorn G; Russo LM; Lin HY; Ausiello DA; Brown D
    Biol Cell; 2006 Apr; 98(4):215-32. PubMed ID: 16563128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide-induced vasopressin-independent activation of aquaporin-2 in the rat kidney.
    Kim S; Choi HJ; Jo CH; Park JS; Kwon TH; Kim GH
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F474-83. PubMed ID: 26109089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water in health and disease: new aspects of disturbances in water metabolism.
    Peters HP; Robben JH; Deen PM; Wetzels JF
    Neth J Med; 2007 Oct; 65(9):325-32. PubMed ID: 17954951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline-Derived Gain-of-Function Variants of Gs
    Miyado M; Fukami M; Takada S; Terao M; Nakabayashi K; Hata K; Matsubara Y; Tanaka Y; Sasaki G; Nagasaki K; Shiina M; Ogata K; Masunaga Y; Saitsu H; Ogata T
    J Am Soc Nephrol; 2019 May; 30(5):877-889. PubMed ID: 30962325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and follow-up of 2 cases of pediatric nephrogenic syndrome of inappropriate antidiuresis resulting from activating mutation in AVPR2 and literature review].
    Chen JJ; Gong CX; Wei LY; Cao BY; Wu D; Liu Y; Li WJ
    Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):125-130. PubMed ID: 33548959
    [No Abstract]   [Full Text] [Related]  

  • 40. Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis.
    Gupta S; Cheetham TD; Lambert HJ; Roberts C; Bourn D; Coulthard MG; Ball SG
    Eur J Endocrinol; 2009 Sep; 161(3):503-8. PubMed ID: 19542240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.